Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MERTK as a novel therapeutic target in head and neck cancer.

Oncotarget - 31 May 2016

von Mässenhausen Anne, Sanders Christine, Thewes Britta, Deng Mario, Queisser Angela, Vogel Wenzel, Kristiansen Glen, Duensing Stefan, Schröck Andreas, Bootz Friedrich, Brossart Peter, Kirfel Jutta, Heasley Lynn, Brägelmann Johannes, Perner Sven

Abstract excerpt

Although head and neck cancer (HNSCC) is the sixth most common tumor entity worldwide therapy options remain limited leading to 5-year survival rates of only 50 %. MERTK is a promising therapeutic target in several tumor entities, however, its role in HNSCC has not been described yet. The aim of our study was to investigate the biological significance of MERTK and to evaluate its potential as a novel therapeutic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to c-Mer Tyrosine Kinase
Share to Head and Neck Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Morpholines

Share to Neoplasm Invasiveness

Share to Proportional Hazards Models

Share to rhoA GTP-Binding Protein

Share to Squamous Cell Carcinoma of Head and Neck

Share to Sulfonamides

Source

Open in PubMed Open full text

Identifiers

PMID: 27081701
DOI: 10.18632/oncotarget.8724
PMCID: PMC5078043

Genes

MERTK

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MERTK as a novel therapeutic target in head and neck cancer.PMID 27081701Read ↗

MERTK Inhibition as a Targeted Novel Cancer TherapySemantic proximity Read ↗

Identifying KRT20 as Key Gene in Lymphatic Metastasis of Head and Neck Squamous Cell CarcinomaSemantic proximity Read ↗

Multifaceted and Intricate Oncogenic Mechanisms of NDRG1 in Head and Neck Cancer Depend on Its C-Terminal 3R-MotifSemantic proximity Read ↗

MERTK receptor tyrosine kinase is a therapeutic target in melanoma.Semantic proximity Read ↗

The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.Semantic proximity Read ↗

Tetraspanin CD9: A friend or foe of head and neck cancer (Review)Semantic proximity Read ↗

The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII.Semantic proximity Read ↗

STYK1 promotes Warburg effect through PI3K/AKT signaling and predicts a poor prognosis in nasopharyngeal carcinomaSemantic proximity Read ↗

Identification of lymphocyte cell-specific protein-tyrosine kinase (LCK) as a driver for invasion and migration of oral cancer by tumor heterogeneity exploitationSemantic proximity Read ↗

Roles of TrkC Signaling in the Regulation of Tumorigenicity and Metastasis of CancerSemantic proximity Read ↗

From Concept to Reality: The Long Road to c-Met and RON Receptor Tyrosine Kinase Inhibitors for the Treatment of CancerSemantic proximity Read ↗

Highly Expressed miR-375 is not an Intracellular Oncogene in Merkel Cell Polyomavirus-Associated Merkel Cell CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.